SCHEMBL20006970

SCHEMBL20006970

Cc1onc(-c2ccccc2)c1C(=O)Nc1ccc(OC(C)C)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 1.00
TSHR P16473 2/20 0.80
MEN1 O00255 1/20 0.80
KMT2A Q03164 1/20 0.80
MAPK1 P28482 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
CYP3A4 P08684 1/20 0.68
CYP2C9 P11712 1/20 0.68
CYP2C19 P33261 1/20 0.68
GHSR Q92847 1/20 0.65
ALDH1A1 P00352 5/20 0.62
L3MBTL1 Q9Y468 2/20 0.61
ALOX12 P18054 1/20 0.61
KDM4E B2RXH2 1/20 0.61
PTGS2 P35354 1/20 0.60
HTT P42858 1/20 0.60
HPGD P15428 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20006965 0.86 TP53 (0.75) TP53TSHRMEN1KMT2AMAPK1
SCHEMBL12585052 0.85 MAPK1 (0.79) TP53TSHRKMT2AMAPK1SMN1; SMN2
SCHEMBL20006967 0.85 TP53 (0.74) TP53TSHRMEN1KMT2AMAPK1
SCHEMBL20006968 0.84 PTGS2 (0.74) TP53TSHRMEN1KMT2AMAPK1
SCHEMBL20006962 0.84 TP53 (0.72) TP53TSHRMEN1KMT2AMAPK1
SCHEMBL13501815 0.84 ALDH1A1 (0.84) TP53TSHRMAPK1SMN1; SMN2GHSR
SCHEMBL12319772 0.81 CYP3A4 (1.00) TP53TSHRMEN1KMT2AMAPK1
SCHEMBL20006969 0.81 MAPK1 (0.72) TP53TSHRMAPK1SMN1; SMN2GHSR
SCHEMBL13501824 0.80 KMT2A (0.69) TP53TSHRMEN1KMT2AMAPK1
SCHEMBL13501814 0.79 ALDH1A1 (0.68) TP53TSHRMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018055235-A1 ISOXAZOLE-AMIDES FOR TREATING CARDIAC DISEASES UNIVERSITY OF HELSINKI (FI) 2018-03-29 WO disclosed